Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.29B | 24.29B | 26.42B | 27.12B | 31.14B | 28.20B |
Gross Profit | 3.95B | 3.95B | 3.94B | 5.20B | 3.53B | 3.79B |
EBITDA | 3.69B | 3.69B | 6.28B | 6.22B | 4.14B | 47.40M |
Net Income | 2.36B | 2.36B | 2.54B | 2.06B | 2.17B | 1.70B |
Balance Sheet | ||||||
Total Assets | 172.90B | 172.90B | 155.08B | 161.97B | 148.77B | 152.57B |
Cash, Cash Equivalents and Short-Term Investments | 29.92B | 29.92B | 25.45B | 33.07B | 27.09B | 23.94B |
Total Debt | 35.58B | 35.58B | 30.63B | 35.11B | 35.24B | 26.04B |
Total Liabilities | 133.01B | 133.01B | 111.73B | 122.19B | 105.41B | 104.65B |
Stockholders Equity | 39.86B | 39.86B | 43.33B | 55.69B | 53.84B | 58.44B |
Cash Flow | ||||||
Free Cash Flow | 1.37B | 0.00 | 1.96B | 5.68B | 5.56B | -41.90M |
Operating Cash Flow | 1.59B | 0.00 | 2.45B | 6.20B | 6.26B | 370.00M |
Investing Cash Flow | 738.10M | 0.00 | 2.52B | 4.44B | 2.82B | 5.94B |
Financing Cash Flow | 1.39B | 0.00 | -9.27B | -3.68B | -4.65B | -8.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $4.62B | 35.27 | 15.89% | 0.49% | 7.18% | 77.84% | |
72 Outperform | $7.43B | 31.23 | 17.01% | 0.24% | 15.08% | 55.10% | |
71 Outperform | $4.43B | 15.84 | 5.69% | 9.72% | -7.74% | 2.25% | |
71 Outperform | $3.16B | 41.05 | 12.56% | ― | -3.80% | 62.94% | |
68 Neutral | $7.03B | 1.81 | 102.24% | ― | 3.62% | 943.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $3.26B | ― | -10.61% | ― | 12.03% | -93.60% |